5 January 2025 in International Journal of Biological Macromolecules
α-Synuclein (Syn) is an intrinsically disordered protein, abundant in presynaptic neurons. It is a constituent of the Lewis Body inclusions as amyloid fibrils, in Parkinson's disease patients. It populates an ensemble of conformations and floats between the free random coil and the membrane-bound α-helical species. E46K is a pathogenic mutant of Syn able to accelerate the formation of fibrils. The lysine in position 46 affects several protein structural properties including its interaction with membranes. We have shown that 3,4-dihydroxyphenylacetic acid (DOPAC), a dopamine metabolite, hampers Syn to form fibrils, interfering with the aggregation process and alters the interaction of the protein and its aggregates with membranes. To understand the mechanism of such alteration, we studied the interplay between Syn and E46K, lipid membranes and DOPAC. The ability of DOPAC to displace the proteins bound to membrane was also tested. Our findings provided a dynamic model of interaction able to explain the different effects of DOPAC on lipid binding properties of Syn and E46K, shedding light on the conformational changes induced by the catechol, which may destabilize the protein interactions with membranes. Understanding these mechanisms could have implications for therapeutic strategies targeting Syn aggregation and membrane interactions in neurodegenerative diseases.
26 August 2025 in Journal of the American Society for Mass Spectrometry
Understanding the structural determinants of antibody stability and aggregation is essential for therapeutic development. In this study, we investigated the unfolding and refolding behavior of bevacizumab under denaturing conditions using dynamic light scattering (DLS), circular dichroism (CD), and hydrogen-deuterium exchange mass spectrometry (HDX-MS). Unfolding was induced by incubating the antibody in 4 M guanidine hydrochloride (Gnd-HCl), followed by refolding through dilution with 1 M Gnd-HCl. Each domain exhibited distinct unfolding kinetics: the CH2 and VH domains unfolded rapidly, while the CH3 domain retained its structure until 45 min, consistent with its known thermodynamic stability. Aggregation, detected by DLS, was prevalent only after 120 min and overnight unfolding, coinciding with CH3 destabilization. Notably, aggregation-prone regions were identified in both the Fc and Fab portions of the antibody. Specifically, interactions at the CH2-CH3 and CH3-CH3 interfaces appear disrupted upon CH3 unfolding, leading to misfolded and aggregation-prone states in both domains. In parallel, the VH CDR H1 region exhibited aberrant protection after refolding, suggesting its involvement in aggregation. These findings highlight the cooperative nature of CH2-CH3 refolding and underscore the critical role of the CH3 stability in preventing aggregation. The involvement of both constant and variable domains emphasizes the complex, interdependent nature of monoclonal antibody aggregation. This work provides mechanistic insights into domain-specific contributions to folding and aggregation, offering guidance for the design of more stable therapeutic antibodies.
7 November 2025 in ACS Infectious Diseases
The SOS response is among the most conserved pathways that promote antibiotic resistance onset in bacteria. This study aimed to identify and characterize small-molecule inhibitors of the SOS response in the opportunistic pathogen Pseudomonas aeruginosa. A library of 318 drug-like compounds was screened for inhibition of RecA-induced LexA autoproteolysis, a key step in SOS activation. One hit compound, 3-(2-sulfanylanilino)propanoic acid, showed dose-dependent inhibition with an IC50 in the mid-micromolar. Differential scanning fluorimetry and isothermal titration calorimetry revealed that A12 binds to both RecA and LexA with a low micromolar affinity. Mass spectrometry analysis demonstrated that A12 covalently modifies RecA via condensation, while it forms a disulfide bond with Cys104 of LexA. Inhibition was diminished under reducing conditions, confirming that disulfide formation is crucial for A12 activity. A12 did not impair LexA's ability to bind SOS box DNA sequences, which is needed to keep the SOS genes repressed. Antimicrobial susceptibility testing of A12 on P. aeruginosa PAO1 showed no additive effect with tested antibiotics, but it impaired P. aeruginosa colonization of A549 lung epithelial cells and survival in THP-1-derived macrophages. While A12's potency requires optimization, it represents a promising scaffold for developing anti-SOS compounds targeting P. aeruginosa.
28 October 2026 in Nature Communications
Proteolytic processing of α-Synuclein (Syn) contributes to the molecular diversity and toxicity of its aggregates in Parkinson’s disease, yet the proteases responsible for disease-relevant truncations remain incompletely defined. Here, we show that thrombin, a serine protease associated with inflammatory conditions, selectively cleaves Syn at Lys6–Gly7, generating a 7–140 fragment despite the presence of multiple potential cleavage sites. Cleavage is modulated by ionic strength and the conformational ensemble of Syn, with more extended states being preferentially cleaved. The resulting 7–140 fragment adopts a more compact conformational ensemble, delays the formation of aggregation-prone species, produces fibrils with altered morphology and shows reduced membrane-induced α-helix formation. Although 7–140 aggregates are modestly less toxic, the truncation also impairs physiological functions of the protein. These findings describe a mechanism by which an inflammation-associated protease, thrombin, may contribute to Parkinson’s disease by selectively modifying Syn structure, aggregation and function.
18 November 2025 in Research Square
Proteolytic processing of α-Synuclein (Syn) contributes to the molecular diversity and toxicity of its aggregates in Parkinson disease (PD), yet the proteases responsible for generating disease-relevant truncations remain incompletely defined. Here, we identify thrombin (Thb) — a serine protease best known for its role in haemostasis — as a highly selective Syn-processing enzyme with relevance to neuroinflammatory conditions. Thb predominantly cleaves Syn at Lys6–Gly7, producing a 7–140 fragment as the major proteolytic species. This reaction displays remarkable site specificity despite multiple lysine residues and is modulated by ionic strength and Syn conformational flexibility. The 7–140 fragment adopts a slightly more compact conformational ensemble, shows reduced membrane binding, and forms fibrils with slower aggregation kinetics and altered morphology compared to the full-length protein. These properties may extend the lifetime of soluble oligomeric intermediates, potentially contributing to chronic Syn-mediated toxicity. Our findings reveal a previously unrecognized link between inflammatory Thb activity and Syn proteostasis, suggesting that neuroinflammation-associated proteases may influence PD progression through selective truncation of Syn.
8 April 2026 in SSRN Electronic Journal
This study analyzes the relationship between light-induced chemical modifications and intrinsic conformation in mAbs. Three therapeutic mAbs, Ipilimumab, Bevacizumab, and Nivolumab, were used as protein models. They were characterized in terms of thermodynamic stability and their susceptibility to oxidation and deamidation was tested as consequence of light irradiation. The commonly modified amino acid residues were identified, as well as the percentages of modification. Moreover, the mAb susceptibility to chemical modification was analyzed in terms of the localization of the residue in the crystallographic structure of the protein. Exposure to specific doses of light (2000–8000 kJ/m²) resulted in two major classes of chemical modifications: oxidation and deamidation. Ipilimumab exhibited the highest levels of modification, followed by Bevacizumab and then Nivolumab. These differences were explained by the interplay between domain folding, local residue environment, and thermal stability profiles. Understanding the relation between mAb structure and susceptibility to chemical modification is extremely important for antibody engineering and their development pipeline.